Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Oh well fun is over

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Sep 13, 2023 9:24pm

209 Views

Post# 35635143

RE:RE:RE:RE:RE:RE:Oh well fun is over

Listen. We told them the reverse split would be sh t. They did not listen with the result we know... total anihilation. They are bad managers and I'm broke because of their bad decisions. I mean you at least make shure you can do a PR like last week right after the reverse split announcement to buffer the effect of such a bad news. They are the reason th e company is probably behind repair. Bad management, bad decision, bad outcome.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China